These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections. Nicolau DP Expert Opin Investig Drugs; 2015; 24(9):1261-73. PubMed ID: 26145447 [TBL] [Abstract][Full Text] [Related]
3. Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections. Alidjanov JF; Fritzenwanker M; Hoffman I; Wagenlehner FM Future Microbiol; 2017 Jun; 12():655-670. PubMed ID: 28338347 [TBL] [Abstract][Full Text] [Related]
4. Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. Hidalgo JA; Vinluan CM; Antony N Drug Des Devel Ther; 2016; 10():2379-86. PubMed ID: 27528799 [TBL] [Abstract][Full Text] [Related]
5. Ceftazidime/Avibactam (Avycaz) -- a new intraveneous antibiotic. Med Lett Drugs Ther; 2015 May; 57(1469):79-80. PubMed ID: 25989198 [No Abstract] [Full Text] [Related]
6. Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. Mawal Y; Critchley IA; Riccobene TA; Talley AK Expert Rev Clin Pharmacol; 2015; 8(6):691-707. PubMed ID: 26420166 [TBL] [Abstract][Full Text] [Related]
8. A β-lactamase inhibitor revival provides new hope for old antibiotics. Garber K Nat Rev Drug Discov; 2015 Jul; 14(7):445-7. PubMed ID: 26129790 [No Abstract] [Full Text] [Related]
9. Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria. Asli A; Brouillette E; Krause KM; Nichols WW; Malouin F Antimicrob Agents Chemother; 2016 Feb; 60(2):752-6. PubMed ID: 26574008 [TBL] [Abstract][Full Text] [Related]
10. Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections. Gardiner BJ; Golan Y Expert Rev Anti Infect Ther; 2016; 14(5):451-63. PubMed ID: 27042762 [TBL] [Abstract][Full Text] [Related]
11. What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? Gentile I; Maraolo AE; Borgia G Expert Rev Anti Infect Ther; 2016 Oct; 14(10):875-8. PubMed ID: 27599088 [No Abstract] [Full Text] [Related]
12. Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. King M; Heil E; Kuriakose S; Bias T; Huang V; El-Beyrouty C; McCoy D; Hiles J; Richards L; Gardner J; Harrington N; Biason K; Gallagher JC Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483952 [TBL] [Abstract][Full Text] [Related]